Jagannathan Ram, Ziolkowski Susan Lynn, Weber Mary Beth, Cobb Jason, Pham Nhat, Long Jin, Anand Shuchi, Lobelo Felipe
Hubert Department of Global Health, Rollins School of Public Health, Emory University, 1518 Clifton Road NE, CNR 7051, Atlanta, GA, 30322, USA.
Division of Nephrology, Stanford University School of Medicine, Palo Alto, CA, USA.
BMC Nephrol. 2018 Sep 12;19(1):230. doi: 10.1186/s12882-018-1032-0.
Patients on dialysis are physically inactive, with most reporting activity levels below the fifth percentile of healthy age-matched groups. Several small studies have reported efficacy of diverse exercise interventions among persons with CKD and those on dialysis. However, no single intervention has been widely adopted in real-world practice, despite a clear need in this vulnerable population with high rates of mortality, frailty, and skilled nursing hospitalizations.
METHODS/DESIGN: We describe a pragmatic clinical trial for an exercise intervention among patients transitioning to dialysis. We will use an existing framework - Exercise is Medicine (EIM) - developed by the American College of Sports Medicine. After undertaking formative qualitative research to tailor the EIM framework to the advanced CKD population (eGFR < 30 ml/min/1.73m), we will randomize 96 patients from two regions-Atlanta and Bay Area-in two intervention arms with incremental levels of clinical-community integration: physical activity assessment during Nephrology clinical visit, brief counseling at pre-dialysis education, and physical activity wearable (group 1) versus group 1 intervention components plus a referral to a free, EIM practitioner-led group exercise program over 16 weeks (group 2; 8 week core intervention; 8-week follow up). We will assess efficacy by comparing between group differences in minutes/week of objectively measured moderate intensity physical activity. To evaluate implementation, we will use questionnaires for assessing barriers to referral, participation and retention along the path of the intervention. Further we will have a plan for dissemination of the intervention by partnering with relevant stakeholders.
The overall goal is to inform the development of a practical, cost-conscious intervention "package" that addresses barriers and challenges to physical activity commonly faced by patients with advanced CKD and can be disseminated amongst interested practices.
ClinicalTrials.gov identifier (Dated:10/17/2017): NCT03311763 .
接受透析治疗的患者身体活动不足,大多数患者报告的活动水平低于健康同龄人组的第五百分位。几项小型研究报告了各种运动干预措施对慢性肾脏病患者和透析患者的疗效。然而,尽管这个脆弱群体死亡率高、身体虚弱且熟练护理住院率高,迫切需要运动干预,但没有一种单一干预措施在实际临床中得到广泛应用。
方法/设计:我们描述了一项针对即将开始透析的患者进行运动干预的实用性临床试验。我们将使用美国运动医学学院开发的现有框架——“运动即良药”(EIM)。在进行形成性定性研究,以使EIM框架适用于晚期慢性肾脏病患者(估算肾小球滤过率<30ml/min/1.73m²)之后,我们将把来自亚特兰大及湾区两个地区的96名患者随机分为两个干预组,两组的临床-社区整合程度逐步增加:在肾病科门诊进行身体活动评估、透析前教育时进行简短咨询以及使用身体活动监测设备(第1组),对比第1组干预措施,第2组还包括转介至由EIM从业者主导的免费团体运动项目,为期16周(8周核心干预;8周随访)。我们将通过比较两组客观测量的中度强度身体活动每周分钟数的差异来评估疗效。为评估实施情况,我们将使用问卷来评估干预过程中转诊、参与和留存的障碍。此外,我们将制定一项与相关利益相关者合作传播该干预措施的计划。
总体目标是为制定一个实用、注重成本的干预“套餐”提供信息,该套餐可解决晚期慢性肾脏病患者身体活动常见的障碍和挑战,并能在相关医疗机构中推广。
ClinicalTrials.gov标识符(日期:二零一七年十月十七日):NCT03311763 。